Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VTL | Vital Therapies, Inc. | 1.50% | 13.51 | 3.3% | $792.68m | |
| AMGN | Amgen Inc. | 2.36% | 204.02 | 1.3% | $749.47m | |
| GILD | Gilead Sciences, Inc. | 0.43% | 63.14 | 0.9% | $384.23m | |
| CELG | Celgene Corporation | 1.53% | 94.74 | 1.3% | $360.74m | |
| ILMN | Illumina, Inc. | 0.49% | 286.17 | 3.5% | $321.19m | |
| BIIB | Biogen Inc. | 1.78% | 231.68 | 1.3% | $305.34m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.11% | 184.94 | 1.9% | $260.38m | |
| EXAS | Exact Sciences Corporation | 1.35% | 119.82 | 24.1% | $245.81m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.66% | 110.85 | 2.0% | $238.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.28% | 296.85 | 2.6% | $212.35m | |
| A | Agilent Technologies, Inc. | 2.18% | 71.11 | 1.6% | $206.33m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.44% | 124.95 | 14.7% | $156.17m | |
| INCY | Incyte Corporation | 3.11% | 83.12 | 2.5% | $97.22m | |
| BMRN | BioMarin Pharmaceutical Inc. | 6.65% | 76.50 | 4.3% | $91.98m | |
| SGEN | Seattle Genetics, Inc. | 3.25% | 79.20 | 6.5% | $90.21m |
Company Profile
Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.